For some investors, they’ve created small fortunes. For others, they’ve brought nothing but misery. For all investors, though, there’s no denying the fact that biotech stocks have kept things interesting if only because they can always supply a binary even traders can treat like a coin toss. The third quarter of 2017 isn’t going to be any different.
Related This ETF Could Take Off In September Delta Air Lines: A Winner Among Legacy Carriers Related DAL Watch These 8 Huge Call Purchases In Tuesday Trade Jim Cramer Advises His Viewers On Delta Air Lines, Pandora And A
In a special episode of Mad Money, Jim Cramer dedicated the entire show to the art and science of technical analysis, picking the best charts from his weekly "Off the Charts" segment and analyzing even closer.
Why study the charts at all? Cramer said it's because charts are like the footpr